芜湖市2012～2016年麻疹流行特征分析

沐小敏; 於秀年; 汪思银; 葛轲; 钱邦群

PDF(1010 KB)

安徽预防医学杂志 ›› 2017, Vol. 23 ›› Issue (4) : 261-264.

疾病控制

芜湖市2012～2016年麻疹流行特征分析

沐小敏, 於秀年, 汪思银, 葛轲, 钱邦群

作者信息 +

Analysis on the epidemiological characteristics of measles in Wuhu city from 2012 to 2016

MU Xiao-min, YU Xiu-nian, WANG Si-yin, GE Ke, QIAN Bang-qun

Author information +

文章历史 +

关键词

麻疹 / 流行特征 / 免疫接种

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用

沐小敏, 於秀年, 汪思银, 葛轲, 钱邦群. 芜湖市2012～2016年麻疹流行特征分析[J]. 安徽预防医学杂志. 2017, 23(4): 261-264

MU Xiao-min, YU Xiu-nian, WANG Si-yin, GE Ke, QIAN Bang-qun. Analysis on the epidemiological characteristics of measles in Wuhu city from 2012 to 2016[J]. Anhui Journal of Preventive Medicine. 2017, 23(4): 261-264

中图分类号： R181

参考文献

[1] 李兰娟,任红.传染病学(第八版)[M].北京:人民卫生出版社,2013:63-68.
[2] 卫生部.全国麻疹监测方案[S].2014.
[3] WHO WPR. Resolution WPR/RC63.5. Elimination of measles and acceleration of rubella control[EB/OL]. WHO WPR2012.Available at http://www.wpro.who.int/about/regional_committee/63/resolutions/WPR_RC63_R5_Measles_elimination_03Oct.pdf.(accessed February2014).
[4] 於秀年,倪进东,钱帮群,等.芜湖市1950-2008年麻疹流行特征分析[J].中华疾病控制杂志,2010,14(7):635-637.
[5] 於秀年,汪思银.芜湖市2009-2011年麻疹监测与流行特征分析[J].安徽预防医学杂志,2012,18(6):407-409.
[6] 曾臻,靳玉惠.2010-2014年合肥市麻疹流行病学特征分析[J].现代预防医学,2016,43(7):241-242.
[7] 马超,苏琪茹,郝利新,等.中国2012-2013年麻疹流行病学特征与消除麻疹进展[J].中国疫苗和免疫,2014,20(3):193-199.
[8] 马超,苏琪茹,郝利新,等.中国2014年麻疹流行病学特征分析[J].疾病监测,2015,30(10):818-823.
[9] 张向阳,崔元凤,王维维.黄山市2007-2013年麻疹流行特征及消除麻疹策略分析[J].安徽预防医学杂志,2012,18(6):407-409.
[10] 任先云,云成,李娜,等.2009-2015年呼和浩特市麻疹流行病学分析[J].现代预防医学,2016,43(22):4040-4043.
[11] 王晓萍,靳玉惠,王蓓,等.合肥市55例小于1岁麻疹病例分析[J].安徽预防医学,2003,9(4):1172-1174.
[12] Seward JF,Orenstein WA.Editorial commentary : A rare event: a measles outbreak in a population with high2-dose measles vaccine coverage [J]. Clin Infect Dis,2012,55(3) : 403-405.
[13] Gans HA,Yasukawa LL,Sung P,et al.Measles humoral and cellmediated immunity in children aged 5 － 10 years after primary measles immunization administered at 6 or 9 months of age[J]. J Infect Dis,2013,207(4) : 574-582.
[14] Poland GA,Jacobson RM, Th ampy AM,et al.Measles reimmunization in children Seronagtive after initial immunization[J].JAMA, 1997,277(14):1156-1158.
[15] Pihlgren M,Tougne C,Bozzotti P,et al.Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigens[J]. J Immunol,2003,170(6) :2824-2832.
[16] WHO.Measles vaccines: WHO position paper[J]. WER,2009,84(35) : 349-360.
[17] Leuridan E,Sabbe M,Van Damme P. Measles outbreak in Europe:susceptibility of infants too young to be immunized[J].Vaccine,2012,30(41) : 5905-5913.
[18] 苏琪茹,徐爱强,Peter Strebel,等.中国消除麻疹的关键技术问题:专家解读共识[J].中国疫苗和免疫,2014,20(3):264-270.
[19] 马蕊,卢莉,张朱佳子,等.2010年含麻疹成分疫苗补充免疫前后北京市麻疹流行特征变化分析[J].中华预防医学杂志,2015,49(12):1036-1041.
[20] 严睿,何寒青,陈恩富,等.浙江省2011年麻疹流行病学特征分析[J].中国疫苗和免疫,2014,20(4):318-323.
[21] Watson JC,Hadler SC,Dykewicz CA,et a1.Measles,mumps,and rubella--vaccine use and strategies for elimination of measles,rubella,and congenital rubella syndrome and control of mumps:recommendations of the Advisory Committee on Immunization Practices(ACIP)[J].MMWR Recomm Rep,1998,47(RR-8):1-57.
[22] Fiebelkorn AP,Seward JF,Orenstein WA. A global perspective of vaccination Of healthcare personnel against measles: Systematic review.LID - S0264-410X(13) 01504-1 [pii]LID-10.1016 /j. vaccine.2013.11.005 [doi][J].Vaccine,2013.